Schreiner MediPharm film blinds blister packs

Published: 4-Jul-2011
Packaging Regulatory

Film is printed with special ink that makes it impervious to light

German packaging specialist Schreiner MediPharm has developed a special film that easily and reliably neutralises blister packs used in clinical drug trials. Hospital staff and patients are thus unable to tell whether the trial drug or a placebo is being administered and are not influenced by the external appearance of the drug’s packaging during the trial.

For efficient blinding of the blister the label must opaquely cover the pack but at the same time the film must be thin enough to allow the pills to be extracted without the exertion of additional force.

The blinding film is printed with special ink that makes the label impervious to light. Due to the specific properties of the material, the film is destroyed if an attempt is made to peel it off.

The material can be used on blister packs of various sizes and exhibits the same properties irrespective of the configuration of the individual cavities.

  • Companies:
  • Schreiner MediPharm
See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Packaging

RFID and smart labels: a new frontier in pharma packaging

Read more
Smart RFID and NFC labels are moving beyond simple identification to enable real-time traceability, automated inventory management and enhanced patient safety, positioning advanced labelling as a strategic tool in pharmaceutical manufacturing and hospital supply chains

Trending Articles

  1. Roche wins CE mark for first blood-based immunoassay to identify ApoE4 Alzheimer's risk variant Roche's Elecsys ApoE4 test has received CE mark approval as the first in-vitro diagnostic immunoassay to detect the ApoE4 genetic variant from a simple blood sample, potentially eliminating the need for confirmatory DNA testing in Alzheimer's patients who do not carry the variant
  2. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for sterile freeze-dried pharmaceuticals
  3. Orphan drug sales to exceed $400bn by 2032, Evaluate report finds Despite FDA policy shifts and the rise of blockbuster obesity drugs, a new Evaluate report confirms rare disease therapies are on track to claim more than a fifth of all global prescription drug sales within a decade
  4. FDA rejects uniQure Huntington's gene therapy AMT-130, demands randomised trial The US regulator has refused to accept uniQure's Phase I/II data for AMT-130 as sufficient for approval, calling for a placebo-controlled study and accusing the company of using a 'distorted' external comparator — a decision that could delay any approval by years
  5. Shilpa Biologicals and mAbTree secure FDA Orphan Drug Designation for rare blood cancer biologic The FDA has granted Orphan Drug Designation to the pair's investigational monoclonal antibody for Essential Thrombocythemia and Polycythemia Vera, two rare chronic blood cancers with significant unmet treatment need

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Packaging

RFID and smart labels: a new frontier in pharma packaging

Smart RFID and NFC labels are moving beyond simple identification to enable real-time traceability, automated inventory management and enhanced patient safety, positioning advanced labelling as a strategic tool in pharmaceutical manufacturing and hospital supply chains
Packaging

Smart RFID labels from Schreiner MediPharm: safety and efficiency in the healthcare sector

The Robust RFID labels from Schreiner MediPharm enable the precise tracking of drugs, reduce medication errors and enhance supply efficiency
Packaging

FINAT award recognises pioneering product in “Innovation” category

At this year’s FINAT Label Competition, Schreiner Group impressed with its Smart Syringe Box from the Schreiner MediPharm business unit
Packaging

Schreiner MediPharm debuts new digital labels for clinical trials

The technology has the potential to replace conventional labels by electronic ones with digital displays in the future
Packaging

Innovative light protection labels for prefilled syringes showcased at Pharmapack 2025

Schreiner MediPharm presents new functional labels for light-sensitive substance
Packaging

Schreiner MediPharm develops protective label for light-sensitive ADC on behalf of WuXi XDC

The pharmaceutical labelling company developed a cover for a light/UV-sensitive ADC drug product contained in a vial on behalf of CRDMO WuXi
Packaging

Schreiner MediPharm to present novel RFID-Labels with digital seal function at CPHI 2024

Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, will be presenting a new RFID-Label with digital first-opening indication at CPHI in Milan
Subscribe now